Lipid based Nanocarriers for Oral Delivery of Cancer Chemotherapeutics: An Insight in the Intestinal Lymphatic Transport

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  2013-03-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/2210304X11303010006
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Lipid-Based Drug Delivery System (LBDDS): An Emerging Paradigm to Enhance Oral Bioavailability of Poorly Soluble Drugs

  2022cites this paper
• Receptor-Targeted Surface-Engineered Nanomaterials for Breast Cancer Imaging and Theranostic Applications.

  2022cites this paper
• Physiologically Based Pharmacokinetic (PBPK) Modeling of RNAi Therapeutics: Opportunities and Challenges.

  2021cites this paper
• Polymer-Lipid Hybrid Systems: Scope of Intravenous-To-Oral Switch in Cancer Chemotherapy

  2020cites this paper
• Surface-Engineered Cancer Nanomedicine: Rational Design And Recent Progress.

  2020cites this paper
• Nanomedicines In Diagnosis And Treatment Of Cancer: An Update.

  2020cites this paper
• Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers

  2017cites this paper
• Phytochemical based nanomedicines against cancer: current status and future prospects

  2017cites this paper
• Docetaxel in cationic lipid nanocapsules for enhanced in vivo activity

  2016cites this paper
• Nanotechnology to Combat Multidrug Resistance in Cancer

  2015cites this paper
• Solid-Nanoemulsion Preconcentrate for Oral Delivery of Paclitaxel: Formulation Design, Biodistribution, and γ Scintigraphy Imaging

  2014cites this paper